Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human P Cadherin ELISA Kit (AC2933)
Cat.#: ASET-1522
Specifications
Description Human P Cadherin ELISA Kit allows for the in vitro quantitative determination of human P Cadherin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 37.5 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 62.5-4000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2261 Mouse Cathepsin B ELISA Kit (AC3672) Quantitative inquiry ASET-1666 Porcine Ghrelin ELISA Kit (AC3077) Quantitative inquiry ASET-1196 Mouse DLL1 ELISA Kit (AC2607) Quantitative inquiry ASET-2519 Human Laminin beta 2 ELISA Kit (AC3930) Quantitative inquiry ASET-1269 Mouse Urocortin ELISA Kit (AC2680) Quantitative inquiry ASET-2126 Human LAMC2 ELISA Kit (AC3537) Quantitative inquiry ASET-2534 Human Orexin Receptor 2 ELISA Kit (AC3945) Quantitative inquiry ASET-1918 Mouse Chrm1 ELISA Kit (AC3329) Quantitative inquiry ASET-2351 Human SNAP25 ELISA Kit (AC3762) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket